Objectives: The purpose of this study was to demonstrate the feasibility of implementing a Clinical Laboratory Improvement Amendments-waived real-time polymerase chain reaction (PCR) molecular test into a community pharmacy setting as part of a collaborative influenza and group A Streptococcus (GAS) disease management program.
Setting And Participants: Two community pharmacy sites in Tennessee.
Practice Description: Patients presenting to the pharmacy with symptoms consistent with influenza or GAS from November 1, 2016, to April 30, 2018.
Practice Innovation: Influenza and GAS management programs based on previously developed protocols occurred at 2 community pharmacies in Tennessee. Pharmacies used the Cobas Liat testing system (Roche Diagnostics). Based on test results and under a collaborative practice agreement, pharmacists dispensed prescription medications for patients with a positive test: oseltamivir for influenza and amoxicillin for GAS. Patients with negative tests were treated with over-the-counter (OTC) medications or referred. Patients testing negative for GAS were asked to consent to having a second throat swab sent for culture.
Evaluation: Number of patients tested, point-of-care test results, and treatment received.
Results: Two hundred and two patients received care at the 2 pharmacies (116 for influenza, 46 for GAS, and 43 for both). Sixty (38%) tested positive for influenza, with 51 receiving an antiviral prescription, and 16 (18%) tested positive and were treated for GAS. No patient testing negative for either or positive for influenza was dispensed an antibiotic. For patients consenting to a follow-up culture, all GAS cultures sent for confirmatory testing were negative.
Conclusion: A protocol-driven community pharmacy-based disease management program using real-time PCR testing for influenza and GAS was able to offer appropriate treatment to patients without overuse of antibiotics.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.japh.2019.07.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ECMO-weaning facilitated by neurally adjusted ventilatory assist (NAVA): a case for principal clarification.
J Artif Organs
December 2024
Department of Anaesthesiology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
The use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) has become increasingly prevalent, particularly in respiratory disease pandemics such as H1N1-influenza and SARS-CoV-2. This surge has emphasized the importance of clear therapy recommendations, improved accessibility to ECMO technology, established ECMO teams, and structured networks to ensure access to specialized care throughout the course of the disease for patients with severe ARDS. Although the initiation criteria for VV-ECMO are well defined, treatment strategies while on ECMO regarding e.
View Article and Find Full Text PDFBackground: Acute necrotizing encephalopathy is a rare acute, explosive, and severe form of encephalopathy that predominantly occurs in children; however, it is infrequent in adults. The patient is typically caused by viral infection, with rapid onset of fever, convulsion, disturbance of consciousness, and other symptoms. It presents symmetrical, multifocal, involving bilateral thalamic damage and other typical imaging features.
View Article and Find Full Text PDFAg-coated Au nanostar-based Lateral Flow Immunoassay for Highly Sensitive Influenza A virus antibody Detection in Colorimetric and Surface-Enhanced Raman Scattering (SERS) modes.
Talanta
December 2024
College of Chemistry and Chemical Engineering and State Key Laboratory of Heavy Oil Processing, China University of Petroleum (East China), Qingdao, 266580, China. Electronic address:
Antibody testing for virus aids diagnosis, promotes vaccination and development, and evaluates antibody treatment efficacy. Hence, it is essential to examine and monitor antibody levels for accurate disease diagnosis and prevention. Lateral Flow Immunoassay (LFIA) is a technique that is known for its simplicity and speed, making it a popular choice for immediate detection.
View Article and Find Full Text PDFDynamic behavior and lineage plasticity of the pulmonary venous endothelium.
Nat Cardiovasc Res
December 2024
Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Repair of the pulmonary vascular bed and the origin of new vasculature remain underexplored despite the critical necessity to meet oxygen demands after injury. Given their critical role in angiogenesis in other settings, we investigated the role of venous endothelial cells in endothelial regeneration after adult lung injury. Here we identified Slc6a2 as a marker of pulmonary venous endothelial cells and generated a venous-specific, inducible Cre mouse line.
View Article and Find Full Text PDFDual-mode and multiplex lateral flow immunoassay: A powerful technique for simultaneous screening of respiratory viruses.
Biosens Bioelectron
December 2024
College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao, 266580, PR China. Electronic address:
Respiratory viral infectious usually exhibit similar clinical symptoms, making a great challenge for their accurate diagnostic in early stages. Herein, we developed a dual-mode and multiplex lateral flow immunoassay (LFIA), in which near-infrared (NIR)-responsive Janus Au-FeO nanoparticles (NPs) were synthesized as new reporters for highly sensitive colorimetric/photothermal detection of H3N2 influenza and SARS-CoV-2 viruses in a single assay. The Janus Au-FeO well combined the NIR responsiveness and high molar absorption coefficient of Au and magnetic properties of FeO.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!